CARLSBAD, Calif. - eTradeWire -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announces today, October 24th, 2022, the release of 96-well plate TELL-Seq™ Library Multiplexing Primers for high throughput sample indexing.

With this expanded indexing capability, our customers/TELL-seq users can pool many samples in one sequencing run, significantly reducing NGS library preparation and sequencing costs. The 96-well plate multiplexing primers include the 10-base indexes that will ensure their compatibility across different Illumina sequencing platforms providing the most stringent nucleotide balance in each sequencing cycle to achieve the optimal performance and highest sequencing quality. The 10-base index primers come in a 96-well plate format with a pierceable seal, making their use with NGS library preparation automation platforms convenient and easy.

More on eTradeWire News

• Metro Commercial brokers deal for BJ's Wholesale Club in West Palm Beach, FL
• IBCT Launches International Crisis Communications Training Program
• Love & Insurance: Managing Marriage and Divorce
• L-Strategies political and business consulting firm launched by partners Angie Wong and Jared Craig with Donna and Stan Fitzgerald
• YMCA of the Rockies Hosts 8th Annual Mountaineering Weekend Celebrating Accessibility of Safe Spaces in the Outdoors for All

When used in combination with the UST's TELL-Seq High Throughput kit, researchers will be able to take advantage of the ultra-long linked-read results to provide unparalleled genomic information up to and exceeding 200Kb gDNA fragments with applications ranging from WGS, phasing, SV detection, metagenomics, and more for small, medium, and large genomes.

With TELL-Seq NGS technology, we've made library preparation easy. Our products effectively improve performance, time, and budget across a broad range of sample types with a proven track record.

Dr. Zhoutao (Tom) Chen, Chief Scientific Officer of UST, stated, "We are further streamlining the TELL-seq workflow by simplifying sample preparation and scaling up throughput in response to increased customer demands."

UST's TELL-Seq is a patent-pending transposase-based linked-read library preparation technology that enables short-read 2nd generation DNA sequencing platforms, such as Illumina sequencers, to produce long-range sequencing results (averaging linked-read molecule length greater than 40kb up to and exceeding 200kb). With a simple workflow, a sequencing-ready library can be prepared in PCR tubes in about 3 hours, cost-effectively, and with minimal lab equipment.

More on eTradeWire News

• UPS Launches Services at Neighborhood Parcel Authorized Shipping Center In Tewksbury MA
• One Of The Late Coolio's Final Interviews Shows Up Online With Tons Of Good Stories
• KDG Wins Best Place to Work Honors
• Used Black 2018 Volkswagen Tiguan for Sale!
• Zilker Partners Expands Recruiting and Digital Marketing Services to Keep Pace with Changing Business Climate

Dr. Aaron U. Levy, GM & Chief Commercial Officer of UST, stated, "TELL-Seq Linked-Long-Read Library technology provides valuable solutions that enrich the short read sequencers by enabling them to produce the long-range results ranging to 200kb and more."

ABOUT UST

Universal Sequencing Technology Corporation (UST), a Boston and San Diego-based NGS biotechnology company, was established by a group of NGS veterans. UST is dedicated to developing the most advanced DNA sequencing technologies and has filed more than 20 provisional patent applications covering linked read NGS library preparation, single-cell sequencing, and groundbreaking 3rd-generation DNA sequencing technologies. UST is poised to lead the next wave of DNA sequencing innovations.

www.universalsequencing.com